General Insurance Article - 1.4 billion longevity cover for AkzoNobel's UK pension fund

Swiss Re announces GBP 1.4 billion longevity insurance cover for AkzoNobel's UK Pension Fund

• Longevity insurance contract covers GBP 1.4 billion (USD 2.2 billion) of liabilities and almost 17 000 members of one of AkzoNobel's UK pension funds
• Swiss Re solidifies position as re-/insurer of choice for longevity

 Swiss Re has completed a GBP 1.4 bil-lion longevity insurance contract with one of the UK pension funds of Akzo Nobel N.V., written through Swiss Re's UK sub-sidiary ReAssure Ltd. The agreement reinforces Swiss Re's position as a leader in the longevity market, where it remains the only insurer to have successfully deployed large net capacity to take on longevity risk directly from a pension fund.
 The agreement covers close to 17 000 individuals and their future contingent beneficiaries who were members of the Akzo Nobel (CPS) Pension Scheme at 1 August 2011.
 Costas Yiasoumi, Head Longevity Solutions, Swiss Re Corporate Solutions, says: "We are proud to once again take the lead in longevity insurance. We offer a unique proposition. Whereas the UK pension longevity market tends to be dominated by intermediaries who write and then sell on the exposure, this deal stands out in that all of the longevity exposure is held on our own balance sheet."
 This deal is consistent with Swiss Re's pioneering work in the longevity insurance market. In 2007, the company was a leader in the longevity hedge market with its benchmark transaction with Friends Provident. In 2009, it closed a GBP 1.0 billion longevity insurance contract for the Royal County of Berkshire Pension Fund. In 2010, the company issued USD 50 million of longevity trend risk bonds to the capital markets through the Kortis Capital Ltd. ("Kortis") securitisation programme.
 The latest transaction confirms that pension funds and insurers are becoming more comfortable with longevity solutions. It also highlights Swiss Re's ability to put its large net capacity to work by creating innovative solutions for both public and corporate sector clients.
 Alison Martin, Member of Swiss Re’s Group Management Board and Head of Life & Health, says: "The pension funds of corporate and public sector organisations are gaining a better understanding of the potential risks arising from their longevity exposures. As a natural home for longevity risk and with a track record in innovation, Swiss Re is in a unique position to engage directly with these funds and create the solutions they need."
 "Our strong mortality position means that Swiss Re has capacity to take on more longevity risk, and maintain our position as the re-/insurer of choice in the UK and abroad."
 AkzoNobel and the trustees chose Swiss Re having evaluated proposals from different counterparties.
 Costas Yiasoumi says: "Longevity contracts are very long-dated and pension fund trustees need counterparties that are in this market for the long haul. As a well-diversified re-/insurer with a 150-year track record, we were able to give AkzoNobel, the pension plan trustees and its advisors the necessary confidence for the long-term."

Back to Index

Similar News to this Story

Unpaid UK as bad debt claims soar to a ten year high
The number of insurance claims made so far this year by UK businesses facing bad debts has reached its highest level in ten years according to latest
Regulation is the biggest barrier to digital innovation
New research released by FIS™ reveals that the greatest barrier to UK financial institutions developing digital products, services and operations is
Insurers ask if GDPR has delivered on its aims
Insurance Europe has published an insight briefing that examines whether the General Data Protection Regulation (GDPR) has delivered on its aims of en

Site Search

Exact   Any  

Latest Actuarial Jobs

Actuarial Login

 Jobseeker    Client
Reminder Logon

APA Sponsors

Actuarial Jobs & News Feeds

Jobs RSS News RSS


Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.